Stay updated on CTX110 in B-Cell Malignancies Clinical Trial
Sign up to get notified when there's something new on the CTX110 in B-Cell Malignancies Clinical Trial page.

Latest updates to the CTX110 in B-Cell Malignancies Clinical Trial page
- Check3 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.4.2 was added. The notice about government funding lapse and the older Revision: v3.4.1 were removed.SummaryDifference0.3%

- Check39 days agoChange DetectedAdded a government funding notice banner and a site version update (v3.4.1); these changes do not affect the study details, eligibility criteria, or trial data on the page.SummaryDifference0.3%

- Check46 days agoChange DetectedAdded glossary display and several study metadata fields (Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted) and removed the estimated indicators and older revision labeling.SummaryDifference0.2%

- Check60 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page; this is a minor site version update that does not affect study details, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check81 days agoChange DetectedThe Locations section was updated with additional sites across the United States, Australia, and Canada, and some previous location blocks were removed; a new revision tag v3.3.3 is now shown.SummaryDifference2%

Stay in the know with updates to CTX110 in B-Cell Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX110 in B-Cell Malignancies Clinical Trial page.